Radiation oncology firm Elekta's Agility multileaf collimator and its volumetric modulated arc therapy (VMAT) technology have been used together for the first time to treat a U.K. cancer patient.
Clinicians at St. James' University Hospital used Agility and Elekta's VMAT, along with the company's Monaco treatment planning system, to treat the patient's tongue cancer, reducing the VMAT delivery time from five minutes to two minutes, according to the firm.
